category
Nature Microbiology
date
Mar 16, 2026
slug
status
Published
summary
发现早产儿梭菌株通过代谢人乳低聚糖产生特定代谢物,可促进双歧杆菌增殖、抑制病原体并减轻炎症,揭示了肠道微生物代谢调控宿主免疫的新机制。
tags
基因编辑
type
Post

📄 原文题目

Clostridia from preterm infants metabolize human milk oligosaccharides to suppress pathobionts and modulate intestinal function in organoids

🔗 原文链接

💡 AI 核心解读

发现早产儿梭菌株通过代谢人乳低聚糖产生特定代谢物,可促进双歧杆菌增殖、抑制病原体并减轻炎症,揭示了肠道微生物代谢调控宿主免疫的新机制。

📝 英文原版摘要

<p>Nature Microbiology, Published online: 16 March 2026; <a href="https://www.nature.com/articles/s41564-026-02297-4">doi:10.1038/s41564-026-02297-4</a></p>Clostridium perfringens lacking perfringolysin O toxin isolated from preterm infants metabolizes human milk oligosaccharide disialyllacto-N-tetraose to produce metabolites that promote the growth of commensal bifidobacteria, inhibit pathogens and suppress inflammation in an organoid model.
经验性使用阿奇霉素改变新冠肺炎患者的上呼吸道微生物组和抗药基因组,但无抗炎益处动力蛋白-动力蛋白结合蛋白-核矩阵蛋白复合物的激活与调控
Loading...